CVRX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CVRx Inc is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock shows mixed signals, with no strong positive catalysts or trading signals to justify immediate action. Holding off for now is recommended.
The MACD is below 0 and negatively contracting, indicating bearish momentum. RSI is neutral at 47.14, with no clear signal. Moving averages are converging, showing indecision. Key support is at 6.852, and resistance is at 8.254. The stock is trading close to its pivot point of 7.553.
The company has nominated Michael Dale to its Board of Directors, which could enhance leadership in cardiovascular treatment. Financials show YoY improvement in revenue, net income, EPS, and gross margin.
The stock has a 50% chance of declining in the next day (-2.03%), week (-8.16%), and month (-1.36%). Analyst sentiment is mixed, with JPMorgan lowering the price target to $6 and maintaining an Underweight rating. The regular market change was -4.26%, indicating recent bearish sentiment.
In Q4 2025, revenue increased by 4.45% YoY to $16.02M. Net income improved by 12.05% YoY but remains negative at -$11.93M. EPS improved by 6.98% YoY to -0.46. Gross margin increased to 86.28%, up 3.65% YoY.
Analyst sentiment is mixed. JPMorgan lowered the price target to $6 with an Underweight rating, citing updates post-Q4 results. Canaccord lowered the price target to $10 but maintained a Buy rating, highlighting improved salesforce productivity and sustained growth potential.
